Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

The objective of this study was to explore pharmacists’ attitudes, knowledge, and experiences in providing naloxone, dispensing buprenorphine, and selling nonprescription syringes following partici

Original research | 2024
About pharmacists, Barriers and enablers, Harm reduction, Illegal drugs, Naloxone, Stigma, Substitution/OAT

We provide a synopsis of the 2024 update of the 2018 National Guideline for the Clinical Management of Opioid Use Disorder, from the Canadian Research Initiative in Substance Matters (CRISM).

Guidelines | 2024
Clinical guidance, Harm reduction, Illegal drugs, Stigma, Substitution/OAT, Treatment/recovery, Withdrawal

This study examines how women's feelings of bodily agency while receiving MMT through Opioid Treatment Programs (OTPs) can impact treatment retention.

Original research | 2024
About PWUD, Advocacy, Crime, Illegal drugs, Legal system/law enforcement, Return to use, Sex/Gender , Stigma, Substitution/OAT, Treatment/recovery

In 2017, the Fraser Health Authority developed a training program for direct service providers designed to address the connection between provider stress and patient care—a mental health and resili

Original research | 2020
About prescribers, Mental health

This study investigates whether there is a community-level relationship between alcohol sales and opioid-related overdose deaths to inform the situating of harm reduction efforts in spaces most lik

Original research | 2024
About PWUD, Alcohol, Harm reduction, Opioids, Overdose

In 2018, the planned opening of a second Needle and Syringe Exchange Program (NSP) unit in Stockholm, Sweden, was stopped with reference to protests from the public.

Original research | 2024
Advocacy, Harm reduction, Injecting drugs, Stigma, Policy/Regulatory

The aim of this review was to classify impacts of climate change for people who use alcohol and other drugs (AoD), as reflected in peer reviewed literature.

Scoping review | 2024
About people who use drugs, Alcohol, Hospitals, Mental health, Substitution/OAT, Transitions in care/treatment, Withdrawal

The aim of this paper is to outline this position with reference to the evidence for harm reduction, and to argue that harm reduction needs to be implemented into mainstream healthcare settings to

Perspective | 2024
About nurses, Alcohol, Barriers and enablers, Drug checking, Harm reduction, Hospitals, Injecting drugs, Overdose, SCS/OPS, Wrap-around services
Slide deck | 2022
About prescribers, Barriers and enablers, Clinical guidance, Harm reduction, Hospitals, Ketamine, Opioids, Substitution/OAT, Withdrawal

This study was undertaken to examine the experiences and perspectives of Indigenous Peoples who use illicit drugs (IPWUID) in the Downtown Eastside of Vancouver regarding the drug poisoning crisis

Original research | 2024
About PWUD, Equity, Harm reduction, Illegal drugs, Indigenous, Legal system/law enforcement, Overdose, Peer/PWLLE program involvement, Poverty

The current qualitative study examines the perspectives of women with opioid use disorder (OUD) and professionals that serve them on barriers to engaging in overdose prevention and harm reduction p

Original research | 2024
Harm reduction, Illegal drugs, Naloxone, Overdose, Substitution/OAT

Drugs sold on cryptomarkets are thought to have lower levels of adulteration and higher strength compared with those sourced off-line.

Original research | 2024
Drug checking, Illegal drugs, Hallucinogens/psychedelics, Stimulants

The Community Urinalysis and Self-Report Project (CUSP) is a low-barrier sentinel surveillance system developed to better understand use of drugs from the unregulated supply.

Report | 2024
About PWUD, Benzodiazepines, Drug checking, Illegal drugs, Injecting drugs, Opioids, Stimulants

Is compulsory unpaid labor essential addiction “therapy” or unjust exploitation?

Original research | 2024
About PWUD, Stigma, Workplace, Treatment/recovery

In an Indigenous Health Service hospital in rural Minnesota, the pharmacy sought to integrate harm reduction and express Sexually Transmitted Infections (STIs) services into its scope of practice.

Report | 2024
About pharmacists, Barriers and enablers, Harm reduction, Indigenous

The number of overdose deaths since 1999 has steadily increased in large part due to the presence of synthetic opioids in the US drug supply.

Commentary | 2024
About prescribers, Hospitals, Illegal drugs, Overdose, Substitution/OAT, Transitions in care/treatment, Treatment/recovery

Safer supply programs are intended to reduce overdose events by limiting people's use of the contaminated drug supply, but the experiences of people receiving hydromorphone vary.

Original research | 2024
About PWUD, Advocacy, Barriers and enablers, Chronic pain, Harm reduction, Injecting drugs, Mental health, Opioids, Overdose, Stigma, Safer supply, Withdrawal

This study aimed to estimate the risk of opioid-related poisonings and mental and behavioural disorders by occupation and industry within a cohort of 1.7 million formerly injured workers.

Original research | 2024
Evidence base, Mental health, Hospitals, Illegal drugs, Opioids, Overdose

In the US context of an unprecedented magnitude of drug overdose deaths and during the fentanyl era, it becomes increasingly imperative to identify longitudinal predictors to inform targeted preven

Original research | 2024
About PWUD, Hospitals, Injecting drugs, Naloxone, Overdose, Substitution/OAT

To assess the risk of treatment discontinuation and mortality among individuals receiving buprenorphine/naloxone vs methadone for the treatment of opioid use disorder.

Original research | 2024
About PWUD, Clinical guidance, Mortality, Opioids, Outcomes, Substitution/OAT, Treatment/recovery

Affiner votre recherche

Mots clés
Format
Région